BACKGROUND:

Universal screening for autism promotes early evidence-based treatment. However, many children are not screened, and screened children are often not referred for autism evaluation.

METHODS:

We implemented process changes in 3 phases: phase 1, changing the screening instrument and adding decision support; phase 2, adding automatic reminders; and phase 3, adding a referral option for autism evaluations in primary care. We analyzed the proportion of visits with autism screening at 2 intervention clinics before and after implementation of process changes versus 27 community clinics (which received only automatic reminders in phase 2) with χ2 test and interrupted time series. We evaluated changes in referral for autism evaluation by calculating the rate ratio for referral.

RESULTS:

In 12 233 visits over 2 years (baseline and phased improvements), autism screening increased by 52% in intervention clinics (58.6%–88.8%; P < .001) and 21% in community clinics (43.4%–52.4%; P < .001). In phase 1, interrupted time series trend for screening in intervention clinics increased by 2% per week (95% confidence interval [CI]: 1.1% to 2.9%) and did not increase in community clinics. In phase 2, screening in the community clinics increased by 0.46% per week (95% CI: 0.03% to 0.89%). In phase 3, the intervention clinic providers referred patients for diagnostic evaluation 3.4 times more frequently (95% CI: 2.0 to 5.8) than at baseline.

CONCLUSIONS:

We improved autism screening and referrals by changing the screening instrument, adding decision support, using automatic reminders, and offering autism evaluation in primary care in intervention clinics. Automatic reminders alone improved screening in community clinics.

Autism is a common neurodevelopmental disorder that affects 1.9% of children in the United States.1  Signs of autism emerge in the second year after birth and cause a range of impairments in adaptive, cognitive, and social functioning throughout the life span.2,3  Through developmental surveillance and screening, pediatricians have a crucial role in identifying children showing signs of autism and in referring them for diagnosis and treatment. Since 2007, the American Academy of Pediatrics has supported screening for autism in all children starting at age 18 months because screening leads to earlier diagnosis, and early diagnosis and treatment improve outcomes.46  Autism treatment that is started before age 4 years is associated with improved cognition and communication compared with treatment started later.7,8  However, only 44% of children with autism have had a comprehensive autism evaluation before age 36 months, suggesting that barriers exist for screening and diagnosis.1  Improving screening could expedite access to services for children with autism during a period of development when early diagnosis and treatment has the best chance of improving long-term outcomes.

Despite the widespread availability of open-source screening instruments and recommendations from the American Academy of Pediatrics for universal screening, many children are not screened for autism.9  There have been several studies in which researchers have attempted to improve screening, with some beginning with 0% of children screened and most achieving screening proportions of 80% to 99%.1015  Although these studies improved screening at intervention sites, generalizability is limited because screening interventions may require extensive training of pediatricians, which may increase the burden on busy clinicians.10,11  Additionally, some studies did not include a comparison site or did not extend the intervention to the comparison site.1113,15  Therefore, there is a need for implementation and evaluation of a comprehensive screening program that could stimulate rapid improvement without intensive and ongoing education, expand successfully to comparison sites, and improve screening and access to diagnosis of autism.

We examined local autism screening practices and observed multiple areas for improvement. Many children were not being screened, and children who had screening results suggestive of autism were often not being referred for autism-specific evaluation. We designed a quality improvement (QI) study to address the following aims: (1) to increase the proportion of visits with screening for autism and (2) to increase the proportion of visits with referrals for autism evaluation.

We studied autism screening at 2 pediatric clinics at The University of Utah (intervention clinics) and 27 community clinics in the same health care system. The intervention clinics are staffed by resident and attending pediatricians, serve numerous children with special health care needs, and have a culture that promotes training and improvement. The community clinics are located in 12 multispecialty health centers in 8 cities, including inner-city, suburban, and semirural locations, serving patients with a range of sociodemographic characteristics.

Before intervention, all clinics were using the Modified Checklist for Autism in Toddlers, Revised (M-CHAT-R) for autism screening.16  The follow-up interview, an additional step in screening to decrease false-positives, was rarely being used, similar to previous reports.17,18  The intervention and community clinics used an electronic health record (EHR) (Epic; Epic Systems Corporation, Verona, WI) with shared infrastructure and management. In Utah, early intervention services do not include autism evaluation and treatment. To access autism services, children must first be referred to a developmental pediatrician or psychologist for autism diagnosis. After children have a diagnosis of autism, Medicaid insurance covers autism therapy. In Utah, health insurance plans that are not covered by the Employee Retirement Income Security Act are mandated to cover autism treatment, contingent on diagnosis.19  Therefore, referral for a diagnostic evaluation is crucial for entry into treatment.

Our QI champions included a pediatric resident, 3 faculty attending pediatricians who worked at the intervention sites, and a faculty pediatrician with expertise in the care of children with autism. The faculty champions had experience in QI methodology. Groups of 1 to 3 pediatric residents joined the improvement team each month during their developmental and behavioral pediatrics rotation and were assigned a task related to improvement activities.

We analyzed screening practices before intervention via process mapping and data analysis. We identified several barriers to successful screening and referral and planned process improvements to address these issues (Table 1). In an analysis of data from the previous 3 years at the intervention clinics, we found that 51% of children were screened for autism and only 10 of 2001 children (0.5%) were diagnosed with autism. The prevalence of autism diagnosed in children aged 4 years in 2016 was threefold greater at other US sites (1.6%) than our clinics.20  We determined that the process of screening in our clinics was not adequately identifying children with autism.

TABLE 1

Process Changes Made to Screening and Referral Processes During Each Phase of the Autism Screening QI Study

PhaseDate InitiatedBarriers to Screening and ReferralProcess ChangeClinics Affected
July 2018 M-CHAT-R had low sensitivity The screening instrument was changed from the M-CHAT-R to the POSI Intervention 
Parents wrote “sometimes” and circled “yes” for inconsistent behaviors 
Parents did not finish questionnaires 
Errors were noted in scoring the paper screening forms An electronic version of the POSI with automatic scoring was created 
Staff was inconsistent in administering screening Staff and providers were trained to administer and enter the POSI into the EHR 
Providers forgot to look at screening results Screening results were automatically populated in note templates Intervention: template use required 
Providers misinterpreted scores A prompt was added to note templates to refer for screening results suggestive of autism Intervention: template use required 
Variation in referral patterns occurred after a screen result was suggestive of autism Community: template use voluntary 
     
November 2018 Providers and staff forgot to screen children at eligible ages. An automatic reminder to screen was added for appropriate ages in the health maintenance screen. Intervention, community 
     
February 2019 Positive autism screening results were frequent; more children had a screen result suggestive of autism on the POSI than the M-CHAT-R. Referral options were expanded to include autism evaluations in primary care with the STAT. Intervention 
PhaseDate InitiatedBarriers to Screening and ReferralProcess ChangeClinics Affected
July 2018 M-CHAT-R had low sensitivity The screening instrument was changed from the M-CHAT-R to the POSI Intervention 
Parents wrote “sometimes” and circled “yes” for inconsistent behaviors 
Parents did not finish questionnaires 
Errors were noted in scoring the paper screening forms An electronic version of the POSI with automatic scoring was created 
Staff was inconsistent in administering screening Staff and providers were trained to administer and enter the POSI into the EHR 
Providers forgot to look at screening results Screening results were automatically populated in note templates Intervention: template use required 
Providers misinterpreted scores A prompt was added to note templates to refer for screening results suggestive of autism Intervention: template use required 
Variation in referral patterns occurred after a screen result was suggestive of autism Community: template use voluntary 
     
November 2018 Providers and staff forgot to screen children at eligible ages. An automatic reminder to screen was added for appropriate ages in the health maintenance screen. Intervention, community 
     
February 2019 Positive autism screening results were frequent; more children had a screen result suggestive of autism on the POSI than the M-CHAT-R. Referral options were expanded to include autism evaluations in primary care with the STAT. Intervention 

We sought to improve autism screening and referral by modifying screening and its supporting processes in the EHR and by better integrating referrals into screening processes. The process improvements were executed in 3 phases (Table 1). We first addressed the sensitivity of screening. Studies conducted in large health care systems in Utah and Pennsylvania revealed that the M-CHAT-R has a sensitivity of 33% to 39% in realistic conditions without research support.18,21  Therefore, we changed our screening instrument to the Parent’s Observation of Social Interaction (POSI), which is embedded in a broadband developmental screen, is shorter than the M-CHAT-R, and includes questions about the consistency of the child’s behavior (ie, sometimes or always).22  The POSI has greater sensitivity than the M-CHAT-R (POSI, 75%–94%; M-CHAT-R, 50%–78%) and similar, although somewhat lower, specificity (POSI, 41%–74%; M-CHAT-R, 54%–84%).22,23 

For intervention phase 1, we implemented screening with the POSI at intervention clinics. We prepared the physicians and staff to use the POSI and interpret the results with in-person training and e-mailed descriptions. We programmed an electronic version of the POSI with automatic scoring into the EHR before implementation. For both the M-CHAT-R and the POSI, all clinics used a paper version, which was then entered by staff into an electronic version with automatic scoring. Thus, the difference between the clinics was the change in instrument and additional training for administering and scoring the POSI. We changed our note templates for the visits at ages 18, 24, and 30 months to include a sentence prompting clinicians to refer a child for autism evaluation when the autism screening result suggested autism risk. The note template was required at intervention clinics and available, but not required, at the community clinics.

In intervention phase 2, to help staff remember to screen every child at the appropriate ages, we added an automatic reminder for autism screening to the EHR health maintenance screen (Fig 1). The health maintenance screen reminds physicians and clinic staff about preventive care, such as vaccinations. We received approval from the local clinical decision support committee to implement the reminder system-wide.24  Therefore, intervention and community clinics were equally affected by the automatic reminder.

FIGURE 1

EHR automatic reminder for autism screening implemented in phase 2 for intervention and community clinics.

FIGURE 1

EHR automatic reminder for autism screening implemented in phase 2 for intervention and community clinics.

Close modal

In intervention phase 3, we added a referral option that clinicians could use for rapid access to autism-specific evaluation. Using an online tutorial, we trained 3 clinicians in the intervention clinics to administer an observational assessment known as the Screening Tool for Autism in Toddlers (STAT) (http://stat.vueinnovations.com/about/stat-training).25  The STAT requires a 30-minute patient visit and has an estimated sensitivity of 78% to 100% and specificity of 57% to 78% for autism.2527  We offered the STAT as a referral option for children who had a POSI result suggestive of autism and for whom the clinician had sufficient concerns about autism that would indicate the need for referral for autism evaluation. Children who had a STAT result suggestive of autism were referred for expedited autism diagnostic evaluation, which was performed by a multidisciplinary team in our university-based developmental assessment clinic. Children who had an STAT result that did not suggest autism did not receive further autism evaluations unless the clinician felt they still needed further evaluation at the developmental clinic. Most children with a negative STAT result were instead referred for other clinically indicated services, such as speech therapy, hearing screening, or early intervention.

We studied well-child visits for children aged 16 to 30 months in a 2-year study from July 2017 to June 2019. We extracted EHR data containing completed screening forms, screening results, referrals placed from eligible visits, and demographic information about subjects.

The primary outcome measure was the proportion of visits with screening performed. The secondary outcome measure was the proportion of visits with a referral for autism evaluation, either with an autism evaluation in primary care by using the STAT or with a diagnostic evaluation at the developmental assessment clinic (both were options for referrals). The proportion of visits with a positive screen result was added as a post hoc descriptive measure to further compare the performances of the M-CHAT-R and the POSI.

We analyzed patient demographics using a χ2 test. We allowed for multiple visits for the same patient because the outcome measures were focused on the clinician’s actions at the visits. We compared the results for intervention versus community clinics with a χ2 test and interrupted time series (ITS) to quantify the rate of change in outcomes over time in the intervention versus community clinics and the intervention phases versus baseline.28  The ITS regression line (trendline) from the start to the end of each phase was quantified and reported as the slope (95% confidence interval [CI]; P). The trendline interruption associated with an event that defined the start of a new study period was the difference between the y-axis values of the trendlines of the new period and previous period, determined at the time of the first measurement after the event.

To analyze the change in referrals associated with intervention, we analyzed the rate ratio of referrals. We applied a mixed-effects Poisson regression, with count of referrals as the outcome, phase of intervention as the main predictor, and nesting by physician to control for referral patterns between physicians. Covariates included the interaction between clinic group and intervention phase, age (<24 vs ≥24 months, including screening at the 30-month visit), race, language, sex, insurance status, and physician training level (resident versus attending). We used backward elimination to discard nonsignificant predictors from the final model. The interaction between phase of intervention and clinic group was significant, so the results were stratified by clinic group and the adjusted rate ratios from the stratified models were reported.

Statistical software was used for the χ2 test and Poisson regression (R version 3.5.2; R Foundation for Statistical Computing, Vienna, Austria) and the ITS (Stata IC 15.1; Stata Corp, College Station, TX).29,30 

We received an exemption for QI from The University of Utah Institutional Review Board.

We studied 12 233 visits (intervention clinics, 4155 visits; community clinics, 8078 visits) over 2 years, including 4889 visits (40%) that were from patients who had >1 visit during the study period. The frequencies of visits from patients of each demographic characteristic are given in Table 2. There were slightly more visits from white, Spanish-speaking, and privately insured children at the intervention clinics than the community clinics (Table 2).

TABLE 2

Demographic Characteristics of Patients Who Were Eligible for Autism Screening in Well-Child Visits

VariableClinicsP
InterventionCommunity
No. well-child visits 4155 8078 — 
Sex, n (%)   .45 
 Male 2159 (52.0) 4138 (52.0)  
 Female 1996 (48.0) 3940 (48.8)  
Age category, mo, n (%)   .77 
 ≥24 2273 (54.7) 3635 (45.0)  
 <24 1882 (45.3) 4443 (55.0)  
Race, n (%)   <.001 
 White 2744 (66.0) 5072 (62.8)  
 Other or undisclosed 1411 (34.0) 3006 (37.2)  
Language, n (%)   <.001 
 English 3425 (82.4) 6869 (85.0)  
 Spanish 575 (13.8) 409 (5.1)  
 Other 155 (3.7) 800 (9.9)  
Insurance, n (%)   <.001 
 Private 2610 (62.8) 4745 (58.7)  
 Medicaid 1341 (32.2) 2850 (35.3)  
 None 204 (4.9) 483 (6.0)  
VariableClinicsP
InterventionCommunity
No. well-child visits 4155 8078 — 
Sex, n (%)   .45 
 Male 2159 (52.0) 4138 (52.0)  
 Female 1996 (48.0) 3940 (48.8)  
Age category, mo, n (%)   .77 
 ≥24 2273 (54.7) 3635 (45.0)  
 <24 1882 (45.3) 4443 (55.0)  
Race, n (%)   <.001 
 White 2744 (66.0) 5072 (62.8)  
 Other or undisclosed 1411 (34.0) 3006 (37.2)  
Language, n (%)   <.001 
 English 3425 (82.4) 6869 (85.0)  
 Spanish 575 (13.8) 409 (5.1)  
 Other 155 (3.7) 800 (9.9)  
Insurance, n (%)   <.001 
 Private 2610 (62.8) 4745 (58.7)  
 Medicaid 1341 (32.2) 2850 (35.3)  
 None 204 (4.9) 483 (6.0)  

—, not applicable.

From baseline to the intervention periods (phases 1–3 combined), the proportion of visits with screening increased by 51% in intervention clinics (58.6%–88.8%) and by 21% in community clinics (43.4%–52.4%) (Table 3). The proportion of referrals increased 1.5-fold in intervention clinics (1.3%–3.3%) but not in community clinics (1.2% vs 1.3%) (Table 3). After changing to the more sensitive POSI in the intervention clinics, the number of visits with a positive screen result increased from 97 (4.7%) to 281 (13.5%). A few providers at the community clinics started using the POSI. However, the POSI was used in community clinics in only 55 of 4046 visits (1.4%), with an average use of 1.7 times per week.

TABLE 3

Comparison of Well-Child Visits With Autism Screening and Referrals in Baseline Versus Intervention Phases and Intervention Versus Community Clinics

Clinic and PeriodNo. VisitsNo. Screens (%)PaNo. Referrals (%)Pa
Intervention      
 Baseline 2076 1217 (58.6)b <.001 26 (1.3) <.001 
 Phases 1, 2, and 3 2079 1847 (88.8)c  68 (3.3)d  
Community      
 Baseline 4032 1750 (43.4)b <.001 49 (1.2) <.7 
 Phases 1, 2, and 3 4046 2119 (52.4)c  54 (1.3)d  
Clinic and PeriodNo. VisitsNo. Screens (%)PaNo. Referrals (%)Pa
Intervention      
 Baseline 2076 1217 (58.6)b <.001 26 (1.3) <.001 
 Phases 1, 2, and 3 2079 1847 (88.8)c  68 (3.3)d  
Community      
 Baseline 4032 1750 (43.4)b <.001 49 (1.2) <.7 
 Phases 1, 2, and 3 4046 2119 (52.4)c  54 (1.3)d  
a

P values for comparison between baseline and phases 1, 2, and 3 combined (for either intervention or community clinics).

b

Screens during baseline: intervention versus community clinics, P < .001.

c

Screens during phases 1, 2, and 3 combined: intervention versus community clinics, P < .001.

d

Referrals during phases 1, 2, and 3 combined: intervention versus community clinics, P < .001.

The ITS revealed that screening was neither increasing nor decreasing during the baseline period in either group (Table 4). During phase 1, screening frequency increased markedly (positive slope) versus baseline in the intervention clinics but not in the community clinics (Fig 2). Screening frequency also increased during phase 3 in the intervention clinics and during phases 2 and 3 in the community clinics. The increase in screening frequency in the intervention group observed in phase 1 was sustained in phases 2 and 3. The trendline interruptions were not significant for intervention or community clinics at any phase break except for a decrease at phase 2 in the intervention clinics. The slope was greater for the intervention clinics than the community clinics in phase 1 but similar in phases 2 and 3.

TABLE 4

ITS for Autism Screening in Intervention and Community Clinics

ParameterInterventionCommunityPb
Value (95% CI)PaValue (95% CI)Pa
Slope      
 Baseline −0.13 (−0.36 to 0.09) .23 0.08 (−0.02 to 0.17) .12 .08 
 Phase 1 2.0 (1.1 to 2.9) <.001 0.36 (−0.19 to 0.90) .20 <.001 
 Phase 2 0.0 (−0.23 to 0.00) .97 0.46 (0.03 to 0.89) .04 .06 
 Phase 3 0.39 (0.13 to 0.64) .003 0.77 (0.06 to 1.48) .03 .32 
Trendline interruption      
 Phase 1 10.4 (−2.5 to 23.2) .11 −4.2 (−10.4 to 2.0) .20 — 
 Phase 2 −7.1 (−14.0 to −1.7) .05 1.4 (−6.5 to 9.3) .73 — 
 Phase 3 −3.6 (−6.8 to 1.6) .22 −1.2 (−1.1 to 0.09) .81 — 
ParameterInterventionCommunityPb
Value (95% CI)PaValue (95% CI)Pa
Slope      
 Baseline −0.13 (−0.36 to 0.09) .23 0.08 (−0.02 to 0.17) .12 .08 
 Phase 1 2.0 (1.1 to 2.9) <.001 0.36 (−0.19 to 0.90) .20 <.001 
 Phase 2 0.0 (−0.23 to 0.00) .97 0.46 (0.03 to 0.89) .04 .06 
 Phase 3 0.39 (0.13 to 0.64) .003 0.77 (0.06 to 1.48) .03 .32 
Trendline interruption      
 Phase 1 10.4 (−2.5 to 23.2) .11 −4.2 (−10.4 to 2.0) .20 — 
 Phase 2 −7.1 (−14.0 to −1.7) .05 1.4 (−6.5 to 9.3) .73 — 
 Phase 3 −3.6 (−6.8 to 1.6) .22 −1.2 (−1.1 to 0.09) .81 — 

Data are reported as slope (percentage per week) or trendline interruption (percentage) with 95% CIs. —, not applicable.

a

P values for the slope indicate a comparison versus a value of 0. P values for the trendline interruption indicate a comparison versus the previous phase.

b

Comparison between intervention and community clinics for each phase.

FIGURE 2

ITS of proportion of visits with autism screening each week: phase 1, change of screening instrument and addition of decision support; phase 2, addition of EHR automatic reminders to screen for autism; phase 3, addition of referral for the STAT in primary care.

FIGURE 2

ITS of proportion of visits with autism screening each week: phase 1, change of screening instrument and addition of decision support; phase 2, addition of EHR automatic reminders to screen for autism; phase 3, addition of referral for the STAT in primary care.

Close modal

In the intervention clinics, referrals were 3.4 times more frequent for visits in phase 3 than in the baseline period (95% CI: 2.0 to 5.8), providers referred boys more frequently than girls, and providers referred less frequently when children had private insurance (Fig 3A). In the community clinics, providers referred boys and older children more frequently, but there was no effect of phase of intervention on referrals (Fig 3B).

FIGURE 3

Adjusted rate ratios (blue points) and 95% CIs (error bars and parentheses) for predictors of referral for autism evaluation by mixed-effects Poisson regression. A, Intervention clinics. B, Community clinics. Rate ratios >1 indicate greater frequency of referral. * P < .05.

FIGURE 3

Adjusted rate ratios (blue points) and 95% CIs (error bars and parentheses) for predictors of referral for autism evaluation by mixed-effects Poisson regression. A, Intervention clinics. B, Community clinics. Rate ratios >1 indicate greater frequency of referral. * P < .05.

Close modal

This QI study increased the proportion of visits with autism screening and referrals for autism-specific evaluation. Effective interventions included training the staff to administer a more sensitive screening instrument, prompting referral for scores suggestive of autism, adding reminders to the EHR, and adding autism evaluation in intervention clinics. Screening increased to almost universal in the intervention clinics, and community clinics continued to have an upward trend at the end of the study. The study may have improved the identification of autism by increasing the frequency of referrals for diagnostic evaluation.

A strength of this study was the comparison between intervention and community clinics within the same health care system, which enabled us to draw conclusions about the changes in screening that were attributable to the intervention and the effectiveness of a remotely administered intervention. Previous studies revealed increased screening with decision support and automatic scoring, but few had comparison sites or implemented the interventions at a comparison site.12,13  In our study, the community clinics had an increase in screening frequency with only automatic reminders, which may be disseminated remotely or with minor educational intervention.

With each study phase, we observed increased referrals for autism-specific evaluations. The change to a more sensitive screening instrument increased the frequency of screening results suggestive of autism and informed our improvement team of the need to implement autism evaluation in primary care to avoid overwhelming our referral system. A novel aspect of our study was the creation of a referral option for autism-specific evaluation within primary care. Most previous studies of autism screening and referral used research-funded evaluations rather than expanding clinical capacity for autism evaluation within primary care.14,16,27,31  One study that used community providers to administer the STAT increased eligibility for autism treatment.32  As practices increase screening frequency and sensitivity, there may be a greater need for primary care or community-based autism evaluations. Increasing screening without the full intervention described here, including the STAT, would likely increase wait times for autism diagnostic testing.

It is unclear why children with private insurance were less likely to be referred for autism evaluation. One possibility is that families with high-deductible insurance plans, similar to those who are uninsured, may be unable to pay for evaluation. There may be a demographic association with parental refusal of provider-offered autism evaluation, similar to associations noted with vaccine refusal.33  Qualitative studies of provider referral decisions and parental reaction to autism screening could help clarify referral bias or parental refusal of services.

Limitations of the current study include the implementation of multiple changes simultaneously and limited understanding of the acceptability of the intervention. We implemented several changes in phase 1 simultaneously, which does not enable us to discern whether one of these changes or the combination stimulated increased screening. We did not evaluate whether the change in screening was acceptable to physicians and families. Other studies have revealed increased self-efficacy of physicians with interventions that included more education.10,11  In future studies, researchers should assess whether physicians felt they understood the screening instrument and judged it effective in screening and referral for diagnosis of autism because this could affect the long-term sustainability of a changed screening process. Furthermore, it may be useful to add discrete EHR fields to enable providers to document the reasons for referral decisions because this information may inform future educational and QI interventions.

In addition, no long-term outcome data are available about our patients. Some children in our study have been diagnosed with autism, but others have not yet been evaluated. Future studies may be used to determine if the increase in screening and referrals improves the time to diagnosis and treatment and long-term functional abilities of children diagnosed with autism. In addition, further study is needed with diagnostic outcomes to fully understand the performance and acceptability of the STAT as a referral option to expedite autism-specific evaluation or rule out autism. In addition, some clinics may be limited in their ability to use the STAT in primary care because of the barriers of training providers and purchasing materials. However, the time-based billing for lengthier appointments and billing for developmental testing help to cover cost.

A shorter and more sensitive screening instrument, staff training, clinical decision support, EHR automatic reminders, and primary care integration of autism evaluations were associated with increased autism screening and referrals.

We thank the pediatric residents at The University of Utah, Dr Kensaku Kawamoto for assistance with EHR clinical decision support, Dr Gregory Stoddard for statistical advice, and Dr Molly Conroy for editing and advice.

Dr Campbell conceptualized and designed the study, collected data, designed and performed analysis, and wrote the initial draft of the manuscript; Dr Carbone conceptualized and designed the study and critically revised the manuscript; Dr Liu conceptualized the study and critically revised the manuscript; Dr Stipelman conceptualized and designed the study, coordinated and supervised data collection, developed electronic health record clinical decision support, designed and performed analysis, and critically revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FUNDING: Supported by the Utah Stimulating Access to Research in Residency Transition Scholar award 1R38HL143605-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funded by the National Institutes of Health (NIH).

CI

confidence interval

EHR

electronic health record

ITS

interrupted time series

M-CHAT-R

Modified Checklist for Autism in Toddlers, Revised

POSI

Parent’s Observation of Social Interaction

QI

quality improvement

STAT

Screening Tool for Autism in Toddlers

1
Maenner
MJ
,
Shaw
KA
,
Baio
J
, et al
.
Prevalence of autism spectrum disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016. [published correction appears in MMWR Morb Mortal Wkly Rep. 2020;69(16):503]
.
MMWR Surveill Summ
.
2020
;
69
(
4
):
1
12
2
Hill
TL
,
Gray
SAO
,
Kamps
JL
,
Enrique Varela
R
.
Age and adaptive functioning in children and adolescents with ASD: the effects of intellectual functioning and ASD symptom severity
.
J Autism Dev Disord
.
2015
;
45
(
12
):
4074
4083
3
Bal
VH
,
Kim
SH
,
Cheong
D
,
Lord
C
.
Daily living skills in individuals with autism spectrum disorder from 2 to 21 years of age
.
Autism
.
2015
;
19
(
7
):
774
784
4
Johnson
CP
,
Myers
SM
;
American Academy of Pediatrics Council on Children With Disabilities
.
Identification and evaluation of children with autism spectrum disorders
.
Pediatrics
.
2007
;
120
(
5
):
1183
1215
5
Dawson
G
,
Rogers
S
,
Munson
J
, et al
.
Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model
.
Pediatrics
.
2010
;
125
(
1
). Available at: www.pediatrics.org/cgi/content/full/125/1/e17
6
Dawson
G
,
Bernier
R
.
A quarter century of progress on the early detection and treatment of autism spectrum disorder
.
Dev Psychopathol
.
2013
;
25
(
4, pt 2
):
1455
1472
7
Rogers
SJ
,
Estes
A
,
Lord
C
, et al
.
Effects of a brief Early Start Denver Model (ESDM)-based parent intervention on toddlers at risk for autism spectrum disorders: a randomized controlled trial
.
J Am Acad Child Adolesc Psychiatry
.
2012
;
51
(
10
):
1052
1065
8
Vivanti
G
,
Dissanayake
C
;
Victorian ASELCC Team
.
Outcome for children receiving the Early Start Denver Model before and after 48 months
.
J Autism Dev Disord
.
2016
;
46
(
7
):
2441
2449
9
Hyman
SL
,
Levy
SE
,
Myers
SM
;
Council on Children With Disabilities
;
Section on Developmental and Behavioral Pediatrics
.
Identification, evaluation, and management of children with autism spectrum disorder
.
Pediatrics
.
2020
;
145
(
1
):
e20193447
10
Carbone
PS
,
Norlin
C
,
Young
PC
.
Improving early identification and ongoing care of children with autism spectrum disorder
.
Pediatrics
.
2016
;
137
(
6
):
e20151850
11
Bright
MA
,
Zubler
J
,
Boothby
C
,
Whitaker
TM
.
Improving developmental screening, discussion, and referral in pediatric practice
.
Clin Pediatr (Phila)
.
2019
;
58
(
9
):
941
948
12
Campbell
K
,
Carpenter
KLH
,
Espinosa
S
, et al
.
Use of a digital Modified Checklist for Autism in Toddlers - Revised with Follow-up to improve quality of screening for autism
.
J Pediatr
.
2017
;
183
:
133
139.e1
13
Downs
SM
,
Bauer
NS
,
Saha
C
,
Ofner
S
,
Carroll
AE
.
Effect of a computer-based decision support intervention on autism spectrum disorder screening in pediatric primary care clinics: a cluster randomized clinical trial
.
JAMA Netw Open
.
2019
;
2
(
12
):
e1917676
14
Miller
JS
,
Gabrielsen
T
,
Villalobos
M
, et al
.
The each child study: systematic screening for autism spectrum disorders in a pediatric setting
.
Pediatrics
.
2011
;
127
(
5
):
866
871
15
Brooks
BA
,
Haynes
K
,
Smith
J
,
McFadden
T
,
Robins
DL
.
Implementation of web-based autism screening in an urban clinic
.
Clin Pediatr (Phila)
.
2016
;
55
(
10
):
927
934
16
Robins
DL
,
Casagrande
K
,
Barton
M
,
Chen
CMA
,
Dumont-Mathieu
T
,
Fein
D
.
Validation of the Modified Checklist for Autism in Toddlers, revised with Follow-up (M-CHAT-R/F)
.
Pediatrics
.
2014
;
133
(
1
):
37
45
17
Monteiro
SA
,
Dempsey
J
,
Berry
LN
,
Voigt
RG
,
Goin-Kochel
RP
.
Screening and referral practices for autism spectrum disorder in primary pediatric care
.
Pediatrics
.
2019
;
144
(
4
):
e20183326
18
Carbone
PS
,
Campbell
K
,
Wilkes
J
, et al
.
Primary care autism screening and later autism diagnosis
.
Pediatrics
.
2020
;
146
(
2
):
e20192314
19
US Department of Labor
.
Health plans and benefits
. Available at: https://www.dol.gov/general/topic/health-plans. Accessed April 12, 2020
20
Shaw
KA
,
Maenner
MJ
,
Baio
J
, et al
.
Early identification of autism spectrum disorder among children aged 4 years - Early Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2016
.
MMWR Surveill Summ
.
2020
;
69
(
3
):
1
11
21
Guthrie
W
,
Wallis
K
,
Bennett
A
, et al
.
Accuracy of autism screening in a large pediatric network
.
Pediatrics
.
2019
;
144
(
4
):
e20183963
22
Smith
NJ
,
Sheldrick
RC
,
Perrin
EC
.
An abbreviated screening instrument for autism spectrum disorders
.
Infant Ment Health J
.
2013
;
34
(
2
):
149
155
23
Salisbury
LA
,
Nyce
JD
,
Hannum
CD
,
Sheldrick
RC
,
Perrin
EC
.
Sensitivity and specificity of 2 autism screeners among referred children between 16 and 48 months of age
.
J Dev Behav Pediatr
.
2018
;
39
(
3
):
254
258
24
Kawamoto
K
,
Houlihan
CA
,
Balas
EA
,
Lobach
DF
.
Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
.
BMJ
.
2005
;
330
(
7494
):
765
25
Stone
WL
,
McMahon
CR
,
Henderson
LM
.
Use of the Screening Tool for Autism in Two-Year-Olds (STAT) for children under 24 months: an exploratory study
.
Autism
.
2008
;
12
(
5
):
557
573
26
Stone
WL
,
Coonrod
EE
,
Turner
LM
,
Pozdol
SL
.
Psychometric properties of the STAT for early autism screening
.
J Autism Dev Disord
.
2004
;
34
(
6
):
691
701
27
Khowaja
M
,
Robins
DL
,
Adamson
LB
.
Utilizing two-tiered screening for early detection of autism spectrum disorder
.
Autism
.
2018
;
22
(
7
):
881
890
28
Wagner
AK
,
Soumerai
SB
,
Zhang
F
,
Ross-Degnan
D
.
Segmented regression analysis of interrupted time series studies in medication use research
.
J Clin Pharm Ther
.
2002
;
27
(
4
):
299
309
29
R Core Team
.
R: A Language and Environment for Statistical Computing
.
Vienna, Austria
:
R Foundation for Statistical Computing
;
2014
30
StataCorp
.
Stata Statistical Software: Release 15
.
College Station, TX
:
StataCorp LLC
;
2017
31
Pierce
K
,
Gazestani
VH
,
Bacon
E
, et al
.
Evaluation of the diagnostic stability of the early autism spectrum disorder phenotype in the general population starting at 12 months. [published correction appears in JAMA Pediatr. 2019;173(8):801]
.
JAMA Pediatr
.
2019
;
173
(
6
):
578
587
32
Rotholz
DA
,
Kinsman
AM
,
Lacy
KK
,
Charles
J
.
Improving early identification and intervention for children at risk for autism spectrum disorder
.
Pediatrics
.
2017
;
139
(
2
):
e20161061
33
Yang
YT
,
Delamater
PL
,
Leslie
TF
,
Mello
MM
.
Sociodemographic predictors of vaccination exemptions on the basis of personal belief in California
.
Am J Public Health
.
2016
;
106
(
1
):
172
177

Competing Interests

POTENTIAL CONFLICT OF INTEREST: Dr Campbell discloses that she is an inventor on a patent related to screening for autism but not described in this publication; Drs Carbone, Liu, and Stipelman have indicated they have no potential conflicts of interest to disclose.

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.